...
机译:2,3,4,5-四氢-1H-3-苯并嗪和6,7,8,9-四羟基-5H-苯并[7] Annulen-7-胺类似物的结构 - 亲和力关系和6,7,8,9-四氢-5H-苯并[7] ,用于成像GLUN2B亚甲基-D-天冬氨酸受体的3,4,5-四氢-1H-3-苯并Z-Benzazepine Congener
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
Univ Munster Inst Pharmaceut &
Med Chem Corrensstr 48 D-48149 Munster Germany;
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
Univ Munster Inst Pharmaceut &
Med Chem Corrensstr 48 D-48149 Munster Germany;
Swiss Fed Inst Technol Inst Pharmaceut Sci Vladimir Prelog Weg 4 CH-8093 Zurich Switzerland;
机译:2,3,4,5-四氢-1H-3-苯并嗪和6,7,8,9-四羟基-5H-苯并[7] Annulen-7-胺类似物的结构 - 亲和力关系和6,7,8,9-四氢-5H-苯并[7] ,用于成像GLUN2B亚甲基-D-天冬氨酸受体的3,4,5-四氢-1H-3-苯并Z-Benzazepine Congener
机译:下调突触包含GluN2B亚基的N-甲基-D-天冬氨酸受体:苯二氮卓戒断期间对CA1神经元α-氨基-3-羟基-5-甲基-4-异恶唑丙酸过度兴奋的生理制动。
机译:黑色素浓缩激素受体1拮抗剂:2,3,4,5-四氢-1H-3-苯并ze庚因衍生物的合成,构效关系,对接研究和生物学评估。
机译:通用机制允许选择性靶向含有GluN2B亚基的N-甲基-D-天冬氨酸受体
机译:下调含有突触的GluN2B亚基的N-甲基-d-天冬氨酸受体:苯二氮卓撤药期间对CA1神经元α-氨基-3-羟基-3-羟基-5-甲基-4-异恶唑丙酸的过度兴奋的生理制动。